Video

US Market Outlook – Bringing Manufacturing Home

Watch Video

US Market Outlook – Bringing Manufacturing Home

While for many years the benefits of a globalized supply chain have been celebrated, the COVID-19 pandemic has highlighted the reliance of many nations on China and India for the production and supply of essential medicines, exposing the vulnerability of the U.S. drug supply chain. This situation has fuelled calls from political leaders and lawmakers for U.S. manufacturers to start producing critical supplies domestically. How realistic is this in practice and what does the future look like?

This webinar was originally aired as part of the CPhI Festival of Pharma.